HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Shin-ichi Takeda Hikaru Matsuda Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Takeda, S.-i. Articles by Matsuda, H. Search for Related Content PubMed PubMed Citation Articles by Takeda, S.-i. Articles by Matsuda, H. Related Collections Related Articles

Ann Thorac Surg 1997;63:1562-1567
© 1997 The Society of Thoracic Surgeons

---

Original Article: General Thoracic

Experimental Bronchiolitis Obliterans Induced by In Vivo HVJ-Liposome–Mediated Endothelin-1 Gene Transfer

First Department of Surgery, Institute for Cellular and Molecular Biology, and Division of Organ Transplantation, Biomedical Research Center, Osaka University Medical School, Osaka, Japan; and Department of Molecular Genetics, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas

Accepted for publication February 11, 1997.

Background. Bronchiolitis obliterans (OB) is a lesion that results when injury to small conducting airways is repaired by a proliferation of fibrous granulation tissue. Bronchiolitis obliterans has emerged as a main cause of morbidity and mortality in the setting of lung and heart-lung transplantation. Endothelin-1 (ET-1), initially discovered as a vasoconstrictive peptide, has a mitogenic activity on vascular smooth cells and airway epithelial cells. Overproduction of endothelin has been reported in patients with OB or chronic rejection after lung transplantation. It is still undetermined whether locally overexpressed ET-1 has a potential impact in the pathogenesis of OB.

Methods. We locally overexpressed ET-1 using ultraviolet irradiation-inactivated hemagglutinating virus of Japan (HVJ)-liposome–mediated in vivo gene transfer. Plasmid DNA of prepro-ET-1 and high mobility group 1 protein were coencapsulated in liposomes, and were introduced into airway epithelial cells by HVJ-mediated membrane fusion. Control animals received instillation of HVJ-liposome with an empty expression cassette. To confirm the efficiency of transfection, HVJ liposome with ß-galactosidase gene was introduced. The expression of ET-1 and ß-galactosidase was assessed by immunohistochemistry.

Results. Bronchial epithelium alveolar cells and alveolar macrophage were stained blue (X-Gal) 1 week after in vivo gene transfer of ß-galactosidase gene, indicating ß-gal activity. In animals 1 to 2 weeks after in vivo transfection of prepro-ET-1 gene, hyperplastic connective tissue plaque was seen in the alveolar duct and small conducting airway, indicating histologically distinctive bronchiolitis obliterans. Strong ET-1–like immunoactivities were seen in the airway epithelial, hyperplastic connective tissue, and alveolar cells. No histopathologic changes were seen in the control animals.

Conclusions. These results suggested that ET-1 may play an important role in the pathogenesis of OB. The effective pharmacologic antagonist or inhibitor may possibly control the progression of disease in patients of OB.

Related Articles

Gene Transfer and Thoracic Surgery: More to Come

Larry R. Kaiser and Steven M. Albelda
Ann. Thorac. Surg. 1997 63: 1527-1528. [Extract] [Full Text]

This article has been cited by other articles:

				N. Shigemura, M. Okumura, S. Mizuno, Y. Imanishi, A. Matsuyama, H. Shiono, T. Nakamura, and Y. Sawa Lung Tissue Engineering Technique with Adipose Stromal Cells Improves Surgical Outcome for Pulmonary Emphysema Am. J. Respir. Crit. Care Med., December 1, 2006; 174(11): 1199 - 1205. [Abstract] [Full Text] [PDF]

				K. Ohmori, S.-i. Takeda, S. Miyoshi, M. Minami, S. Nakane, M. Ohta, Y. Sawa, and H. Matsuda Application of HVJ-liposome mediated gene transfer in lung transplantation--distribution and transfection efficiency in the lung Eur. J. Cardiothorac. Surg., May 1, 2005; 27(5): 768 - 773. [Abstract] [Full Text] [PDF]

				K. Ohmori, S.-i. Takeda, S. Miyoshi, M. Minami, S. Nakane, M. Ohta, Y. Sawa, and H. Matsuda Attenuation of lung injury in allograft rejection using NF-{kappa}B decoy transfection--novel strategy for use in lung transplantation Eur. J. Cardiothorac. Surg., January 1, 2005; 27(1): 23 - 27. [Abstract] [Full Text] [PDF]

				T. F. Luscher and M. Barton Endothelins and Endothelin Receptor Antagonists : Therapeutic Considerations for a Novel Class of Cardiovascular Drugs Circulation, November 7, 2000; 102(19): 2434 - 2440. [Abstract] [Full Text] [PDF]

				N. Nagaya, C. Yokoyama, S. Kyotani, M. Shimonishi, R. Morishita, M. Uematsu, T. Nishikimi, N. Nakanishi, T. Ogihara, M. Yamagishi, et al. Gene Transfer of Human Prostacyclin Synthase Ameliorates Monocrotaline-Induced Pulmonary Hypertension in Rats Circulation, October 17, 2000; 102(16): 2005 - 2010. [Abstract] [Full Text] [PDF]

				H. Saito, H. Nakamura, S. Kato, S. Inoue, M. Inage, M. Ito, and H. Tomoike Percutaneous in vivo gene transfer to the peripheral lungs using plasmid-liposome complexes Am J Physiol Lung Cell Mol Physiol, October 1, 2000; 279(4): L651 - L657. [Abstract] [Full Text] [PDF]

				B. Hocher, A. Schwarz, K. A. Fagan, C. Thöne-Reineke, K. El-Hag, H. Kusserow, S. Elitok, C. Bauer, H.-H. Neumayer, D. M. Rodman, et al. Pulmonary Fibrosis and Chronic Lung Inflammation in ET-1 Transgenic Mice Am. J. Respir. Cell Mol. Biol., July 1, 2000; 23(1): 19 - 26. [Abstract] [Full Text]

				S. Doi, N. Smedira, and P. A. Murray Pulmonary vasoregulation by endothelin in conscious dogs after left lung transplantation J Appl Physiol, January 1, 2000; 88(1): 210 - 218. [Abstract] [Full Text] [PDF]

				L. R. Kaiser and S. M. Albelda Gene Transfer and Thoracic Surgery: More to Come Ann. Thorac. Surg., June 1, 1997; 63(6): 1527 - 1528. [Full Text]